Search Tag: obsessive-compulsive disorder
2020 14 Feb
For the first time, an AI-made drug has reached the clinical trials stage. Called DSP-1181, the pharmaceutical drug created by AI technology to treat obsessive-compulsive disorder, is in phase 1 trials in Japan. You might also like: EIT Awards €6 mln to Health Start-ups The drug is a result of UK-based Exscientia....Read more